T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.11B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 3 |
EQT Corp
EQT
|
+$1.31B |
| 4 |
Colgate-Palmolive
CL
|
+$1.08B |
| 5 |
Adobe
ADBE
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.92B |
| 2 |
UnitedHealth
UNH
|
+$1.78B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.55B |
| 4 |
Ross Stores
ROST
|
+$1.54B |
| 5 |
ASML
ASML
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.61% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 11.05% |
| 4 | Financials | 10.6% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
GoPro
GPRO
$117M
| $319K | ﹤0.01% |
76,862
+1,526
| +2% | +$6.54K |
|
|
NFBK
2327
DELISTED
Northfield Bancorp
NFBK
| $318K | ﹤0.01% |
28,893
+640
| +2% | +$6.84K |
|
|
ORC
2328
Orchid Island Capital
ORC
$1.32B
| $317K | ﹤0.01% |
30,617
+889
| +3% | +$9.19K |
|
|
VERV
2329
DELISTED
Verve Therapeutics
VERV
| $317K | ﹤0.01% |
16,873
+1,440
| +9% | +$24K |
|
|
SEI
2330
Solaris Energy Infrastructure
SEI
$3.94B
| $317K | ﹤0.01% |
38,028
+5,042
| +15% | +$40.4K |
|
|
AGEN
2331
Agenus
AGEN
$315M
| $316K | ﹤0.01% |
9,854
+516
| +6% | +$16.5K |
|
2332
Hillman Solutions
HLMN
$1.71B
| $315K | ﹤0.01% |
34,961
+9,951
| +40% | +$83K |
|
2333
Mesa Laboratories
MLAB
$633M
| $315K | ﹤0.01% |
2,445
+81
| +3% | +$12.3K |
|
2334
Cerus
CERS
$572M
| $314K | ﹤0.01% |
127,379
+3,325
| +3% | +$7.9K |
|
2335
On Holding
ONON
$10.6B
| $313K | ﹤0.01% |
9,459
-1,085
| -10% | -$33K |
|
|
TRST
2336
Trustco Bank Corp NY
TRST
$971M
| $313K | ﹤0.01% |
10,926
+216
| +2% | +$6.34K |
|
2337
Community Trust Bancorp
CTBI
$1.44B
| $312K | ﹤0.01% |
8,764
+179
| +2% | +$6.44K |
|
2338
DocGo
DCGO
$64.5M
| $312K | ﹤0.01% |
33,220
+17,603
| +113% | +$154K |
|
|
TPIC
2339
DELISTED
TPI Composites
TPIC
| $312K | ﹤0.01% |
30,043
+1,454
| +5% | +$16.3K |
|
|
INBX
2340
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $312K | ﹤0.01% |
+12,011
| New | +$281K |
|
|
HSII
2341
DELISTED
Heidrick & Struggles
HSII
| $311K | ﹤0.01% |
11,714
+295
| +3% | +$7.78K |
|
|
CWEN.A
2342
DELISTED
Clearway Energy Class A
CWEN.A
| $310K | ﹤0.01% |
11,480
-1,395
| -11% | -$40.4K |
|
|
FORG
2343
DELISTED
ForgeRock, Inc.
FORG
| $309K | ﹤0.01% |
+15,035
| New | +$301K |
|
2344
CareDx
CDNA
$2.45B
| $308K | ﹤0.01% |
36,150
+4,640
| +15% | +$38.7K |
|
2345
Distribution Solutions Group
DSGR
$1.61B
| $308K | ﹤0.01% |
11,810
-924
| -7% | -$21.7K |
|
2346
Hingham Institution for Saving
HIFS
$686M
| $306K | ﹤0.01% |
1,435
+168
| +13% | +$34.2K |
|
2347
Hyster-Yale Materials Handling
HY
$617M
| $306K | ﹤0.01% |
5,479
-1,155
| -17% | -$59.1K |
|
2348
Kopin
KOPN
$898M
| $306K | ﹤0.01% |
141,800
-37,300
| -21% | -$55.9K |
|
|
CTO
2349
CTO Realty Growth
CTO
$823M
| $305K | ﹤0.01% |
17,759
+2,436
| +16% | +$40.2K |
|
2350
Lifestance Health
LFST
$4.67B
| $305K | ﹤0.01% |
33,297
+19,674
| +144% | +$163K |
|
Similar funds
T. Rowe Price Associates's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
- T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
- T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
- T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
- T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
- T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.
Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.